跳至主要内容
临床试验/ACTRN12620001128987
ACTRN12620001128987招募中2 期

Effect of single versus split dose enoxaparin post elective neurointervention on occurrence of thromboembolic events – a randomised study

Professor Alan Coulthard0 个研究点目标入组 124 人开始时间: 2020年10月30日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients admitted for elective endovascular treatment of intracranial aneurysm are eligible for inclusion.
  • Participants should understand the project and provide voluntary consent
  • Eligible patients will be admitted to the study if at the end of the endovascular procedure the operator determines that a period of post procedural anticoagulation is clinically indicated. The three most common reasons for this are:
  • 1) Placement of an indwelling endovascular device, such as a stent
  • 2) Presence of procedural platelet aggregation
  • 3) Perceived increased risk of thromboembolic events due to
  • (3a) large area of coil exposure at aneurysm neck
  • (3b) loop protrusion into parent artery

排除标准

  • - Under 18 years of age (i.e. paediatric population)
  • - Patients presenting with acute subarachnoid haemorrhage
  • - Patients with significantly impaired renal function (eGFR < 30)
  • - Patients not suitable for 3T MR imaging (e.g. pacemakers)
  • - Pregnant women
  • - Patients deemed not to require anti-coagulation post-procedure

研究者

发起方
Professor Alan Coulthard

相似试验